United States · FDA National Drug Code directory
Amoxicillin and Clavulanate Potassium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-025_b094fa0e-afc6-46ed-a2ab-105722623e38
- Product NDC
- 59651-025
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Amoxicillin and Clavulanate Potassium
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190419
- Source listing expiry
- 20271231
Source-listed ingredients
- AMOXICILLIN — 125 mg/5mL
- CLAVULANATE POTASSIUM — 31.25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (59651-025-01) · 59651-025-01
- 150 mL in 1 BOTTLE (59651-025-55) · 59651-025-55
- 75 mL in 1 BOTTLE (59651-025-75) · 59651-025-75
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →